Literature DB >> 7803265

Established IL-2-dependent double-negative (CD4- CD8-) TCR alpha beta/CD3+ ATL cells: induction of CD4 expression.

Y Yamada1, M Fujita, H Suzuki, S Atogami, H Sohda, K Murata, K Tsukasaki, S Momita, T Kohno, T Maeda.   

Abstract

We established IL-2-dependent T cells from an adult T-cell leukaemia (ATL) patient whose leukaemic cells changed from CD4 single-positive in the initial phase to double-negative (CD4- CD8-) at the time of exacerbation. The cells termed SO-4 were of ATL cell origin and showed the double-negative TCR alpha beta/CD3+ T-cell phenotype. SO-4 cells acquired CD4 antigen expression following stimulation with concanavalin A (ConA) or immobilized anti-CD3 antibody. The induction was inhibited by herbimycin A, an inhibitor of protein tyrosine kinase (PTK) activity. No CD4 mRNA was detectable in unstimulated SO-4 cells but a 3.0 kb signal specific for CD4 mRNA was detected after stimulation. These findings indicate that SO-4 cells return to their original phenotype (CD4 single-positive) by stimulation involving PTK. The results indicate that there is a pathway of phenotypic cycling between CD4 single-positive and double-negative T cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7803265     DOI: 10.1111/j.1365-2141.1994.tb05012.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

1.  A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization.

Authors:  Ken Murata; Toshihisa Hayashibara; Kazuyuki Sugahara; Akiko Uemura; Taku Yamaguchi; Hitomi Harasawa; Hiroo Hasegawa; Kazuto Tsuruda; Toshiro Okazaki; Takehiko Koji; Takayuki Miyanishi; Yasuaki Yamada; Shimeru Kamihira
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

2.  Clinical and oncologic implications in epigenetic down-regulation of CD26/dipeptidyl peptidase IV in adult T-cell leukemia cells.

Authors:  Tomohiro Tsuji; Kazuyuki Sugahara; Kazuto Tsuruda; Akiko Uemura; Hitomi Harasawa; Hiroo Hasegawa; Yukio Hamaguchi; Masao Tomonaga; Yasuaki Yamada; Shimeru Kamihira
Journal:  Int J Hematol       Date:  2004-10       Impact factor: 2.490

3.  Fas gene mutation in the progression of adult T cell leukemia.

Authors:  T Maeda; Y Yamada; R Moriuchi; K Sugahara; K Tsuruda; T Joh; S Atogami; K Tsukasaki; M Tomonaga; S Kamihira
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

4.  Heat shock protein 90 inhibitor NVP-AUY922 exerts potent activity against adult T-cell leukemia-lymphoma cells.

Authors:  Hiroaki Taniguchi; Hiroo Hasegawa; Daisuke Sasaki; Koji Ando; Yasushi Sawayama; Daisuke Imanishi; Jun Taguchi; Yoshitaka Imaizumi; Tomoko Hata; Kunihiro Tsukasaki; Naoki Uno; Yoshitomo Morinaga; Katsunori Yanagihara; Yasushi Miyazaki
Journal:  Cancer Sci       Date:  2014-11-05       Impact factor: 6.716

5.  Identification of genes associated with the progression of adult T cell leukemia (ATL).

Authors:  T Kohno; R Moriuchi; S Katamine; Y Yamada; M Tomonaga; T Matsuyama
Journal:  Jpn J Cancer Res       Date:  2000-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.